Zobrazeno 1 - 10
of 184
pro vyhledávání: '"Conor E Steuer"'
Autor:
Matthew Johnson, Jameel Muzaffar, Xuefeng Wang, Christine H Chung, Jose R Conejo-Garcia, Michael J Schell, Kedar Kirtane, Priyanka Bhateja, Marcelo Bonomi, Feifei Song, Jiannong Li, Sean J Yoder, Jose A Guevara-Patino, James W Rocco, Conor E Steuer, Nabil F Saba
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 6 (2022)
Externí odkaz:
https://doaj.org/article/5c07de39e3c8402aa41c38e7422c0643
Autor:
James R. Janopaul‐Naylor, Manali Rupji, Rachel A. Tobillo, Joshua W. Lorenz, Jeffrey M. Switchenko, Sibo Tian, Azeem S. Kaka, David C. Qian, Ashley J. Schlafstein, Conor E. Steuer, Jill S. Remick, Soumon Rudra, Mark W. McDonald, Nabil F. Saba, William A. Stokes, Mihir R. Patel, James E. Bates
Publikováno v:
Head & Neck. 45:658-663
Postoperative mortality for oropharynx squamous cell carcinoma (OPSCC) with transoral robotic surgery (TORS) varies from 0.2% to 6.5% on trials; the real-world rate is unknown.NCDB study from 2010 to 2017 for patients with cT1-2N0-2M0 OPSCC with Char
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da33aeb2a92951ab660085c3b4248d0f
https://doi.org/10.1002/hed.27282
https://doi.org/10.1002/hed.27282
Autor:
Neal S. McCall, Hamilton S. McGinnis, James R. Janopaul-Naylor, Aparna H. Kesarwala, Sibo Tian, William A. Stokes, Joseph W. Shelton, Conor E. Steuer, Jennifer W. Carlisle, Ticiana Leal, Suresh S. Ramalingam, Jeffrey D. Bradley, Kristin A. Higgins
Publikováno v:
Radiotherapy and Oncology. 174:133-140
Higher estimated radiation doses to immune cells (EDIC) have correlated with worse overall survival (OS) in patients with locally-advanced non-small cell lung cancer (NSCLC) prior to the PACIFIC trial, which established consolidative durvalumab as st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47a32211184d7930da6bea87a9068085
https://doi.org/10.1016/j.radonc.2022.07.015
https://doi.org/10.1016/j.radonc.2022.07.015
Autor:
Kedar Kirtane, Aasha I. Hoogland, Xiaoyin Li, Yvelise Rodriguez, Kelsey Scheel, Brent J. Small, Laura B. Oswald, Jameel Muzaffar, Julie A. Kish, Marcelo Bonomi, Priyanka Bhateja, Nabil F. Saba, Conor E. Steuer, Christine H. Chung, Heather S. L. Jim
Publikováno v:
Head & Neck.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3a6e5cfd306018cba5845bb04ce7631
https://doi.org/10.1002/hed.27388
https://doi.org/10.1002/hed.27388
Autor:
Helena A. Yu, Channing Yu, David Sternberg, Lihui Zhao, Yang Qiu, Zhenhao Qi, Rong Shi, Michele Vigliotti, Sang-We Kim, James Chih-Hsin Yang, Haruyasu Murakami, Conor E. Steuer, Kathryn A. Gold, Marianna Koczywas, Dong-Wan Kim, Makoto Nishio, Hidetoshi Hayashi, Melissa L. Johnson, Wu-Chou Su, Christina Baik, Pasi A. Jänne
Supplementary Tables and Figures from Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor–Resistant, EGFR-Mutated Non–Small Cell Lung Cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e0913bf11b81be3fed5251a76c335ef
https://doi.org/10.1158/2159-8290.22540561.v1
https://doi.org/10.1158/2159-8290.22540561.v1
Autor:
Nabil F. Saba, Zhuo G. Chen, Dong M. Shin, Taofeek K. Owonikoko, Cynthia Cohen, Mark W. El-Deiry, Kelly R. Magliocca, Yuan Liu, Mihir R. Patel, Sreenivas Nannapaneni, Christopher C. Griffith, Conor E. Steuer
PD-L1 and PD-1 Immunohistochemistry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d75199ce36787da1b1e9c75cf5e0f88
https://doi.org/10.1158/1535-7163.22504843
https://doi.org/10.1158/1535-7163.22504843
Autor:
Nabil F. Saba, Zhuo G. Chen, Dong M. Shin, Taofeek K. Owonikoko, Cynthia Cohen, Mark W. El-Deiry, Kelly R. Magliocca, Yuan Liu, Mihir R. Patel, Sreenivas Nannapaneni, Christopher C. Griffith, Conor E. Steuer
We explored potential associations of the PD-1/PD-L1/PD-L2 pathway with clinical characteristics, outcome, and expression of EGFR, HER2, HER3 in oropharyngeal squamous cell carcinoma (OPSCC) using an institutional database. Protein expression was ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b75274d7caedff82cc35381ae2eab73
https://doi.org/10.1158/1535-7163.c.6537868.v1
https://doi.org/10.1158/1535-7163.c.6537868.v1
Autor:
Helena A. Yu, Channing Yu, David Sternberg, Lihui Zhao, Yang Qiu, Zhenhao Qi, Rong Shi, Michele Vigliotti, Sang-We Kim, James Chih-Hsin Yang, Haruyasu Murakami, Conor E. Steuer, Kathryn A. Gold, Marianna Koczywas, Dong-Wan Kim, Makoto Nishio, Hidetoshi Hayashi, Melissa L. Johnson, Wu-Chou Su, Christina Baik, Pasi A. Jänne
Receptor tyrosine-protein kinase ERBB3 (HER3) is expressed in most EGFR-mutated lung cancers but is not a known mechanism of resistance to EGFR inhibitors. HER3-DXd is an antibody–drug conjugate consisting of a HER3 antibody attached to a topoisome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bd957a9a3288a8b6971922207643e48
https://doi.org/10.1158/2159-8290.c.6549412
https://doi.org/10.1158/2159-8290.c.6549412
Autor:
Nabil F. Saba, Zhuo G. Chen, Dong M. Shin, Taofeek K. Owonikoko, Cynthia Cohen, Mark W. El-Deiry, Kelly R. Magliocca, Yuan Liu, Mihir R. Patel, Sreenivas Nannapaneni, Christopher C. Griffith, Conor E. Steuer
PD-L1 and PD-1 Immunohistochemistry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::361db8ce44315ea8ca5d42d32679a1a7
https://doi.org/10.1158/1535-7163.22504840
https://doi.org/10.1158/1535-7163.22504840
Autor:
Nabil F. Saba, Conor E. Steuer, Asari Ekpenyong, Ashley McCook-Veal, Kelly Magliocca, Mihir Patel, Nicole C. Schmitt, William Stokes, James E. Bates, Soumon Rudra, Jill Remick, Mark McDonald, Marin Abousaud, Aik Choon Tan, Muhammad Zaki Hidayatullah Fadlullah, Ritu Chaudhary, Jameel Muzaffar, Kedar Kirtane, Yuan Liu, Georgia Z. Chen, Dong M. Shin, Yong Teng, Christine H. Chung
Publikováno v:
Nat Med
Anti-programmed cell death protein 1 (PD-1) therapy is a standard of care in recurrent metastatic head and neck squamous cell carcinoma (RMHNSCC). Vascular endothelial growth factor inhibitors, including tyrosine kinase inhibitors, have immunomodulat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c3f7a8d7cc7589573626837a085c392
https://europepmc.org/articles/PMC10205145/
https://europepmc.org/articles/PMC10205145/